Quinn Opportunity Partners LLC Amarin Corp Plcuk Transaction History
Quinn Opportunity Partners LLC
- $939 Million
- Q3 2024
A detailed history of Quinn Opportunity Partners LLC transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Quinn Opportunity Partners LLC holds 597,550 shares of AMRN stock, worth $262,922. This represents 0.04% of its overall portfolio holdings.
Number of Shares
597,550
Previous 597,550
-0.0%
Holding current value
$262,922
Previous $412,000
8.74%
% of portfolio
0.04%
Previous 0.05%
Shares
10 transactions
Others Institutions Holding AMRN
# of Institutions
177Shares Held
65.1MCall Options Held
258KPut Options Held
98K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$10.9 Million3.89% of portfolio
-
Kynam Capital Management, LP Princeton, NJ12.4MShares$5.46 Million0.64% of portfolio
-
Eversept Partners, LP New York, NY3.31MShares$1.46 Million0.16% of portfolio
-
Morgan Stanley New York, NY2.55MShares$1.12 Million0.0% of portfolio
-
Scp Investment, LP2.5MShares$1.1 Million1.16% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $177M
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...